Review
Recommendations for the management and treatment of dyslipidemia
Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias
J. George Fodor, Jiri J. Frohlich, Jacques J.G. Genest, P. Ruth McPherson and ; for the Working Group on Hypercholesterolemia and Other Dyslipidemias
CMAJ May 16, 2000 162 (10) 1441-1447;
J. George Fodor
Jiri J. Frohlich
Jacques J.G. Genest Jr.
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Recommendations for the management and treatment of dyslipidemia
J. George Fodor, Jiri J. Frohlich, Jacques J.G. Genest, P. Ruth McPherson
CMAJ May 2000, 162 (10) 1441-1447;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Assessment of Coronary Risk Based on Cumulative Exposure to Lipids in Systemic Lupus Erythematosus
- The quantitative assessment of Motivational Interviewing using Co-active Life Coaching Skills as an intervention for adults struggling with obesity
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial
- Applying the Evidence: Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals?
- Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus
- Are patients with hyperlipidemia undertreated?: Study of patients admitted to hospital with coronary events
- Risk Equation Determining Unsuccessful Cannulation Events and Failure to Maturation in Arteriovenous Fistulas (REDUCE FTM I)
- Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial
- The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study
- Relationship between number, timing, and type of pharmacist interventions and patient outcomes
- The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed
- Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries
- Adverse effects of antiretroviral therapy for HIV infection
- Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study
- Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
- Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men
- Prevention of Cardiovascular Ischemic Events: High-Risk and Secondary Prevention
- Lipid lowering to delay the progression of coronary artery disease
- Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry
- References
- Common problems in the management of hypertriglyceridemia
- Specificity of the commonly used enzymatic assay for plasma cholesterol determination
- Microalbuminuria in diabetes mellitus
- Can Measurement of Serum Apolipoprotein B Replace the Lipid Profile Monitoring of Patients with Lipoprotein Disorders?
- Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol
- Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides : Evidence From Men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study
- High-protein diets in hyperlipidemia: effect of wheat gluten on serum lipids, uric acid, and renal function
- Deterioration of the Metabolic Risk Profile in Women: Respective contributions of impaired glucose tolerance and visceral fat accumulation
- Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines